The rapid mutation rates of RNA viruses create significant challenges for existing molecular diagnostic tools, according to new research. Conventional methods such as reverse transcription quantitative polymerase chain reaction (RT-qPCR) are prone to reduced effectiveness when genetic changes occur at primer or probe binding sites. This can result in failures to detect emerging viral variants during outbreaks, potentially allowing them to spread undetected and hindering containment efforts.
Researchers propose that future diagnostic technologies should follow two main strategies to address these issues. The first approach focuses on developing mutation-tolerant detection systems for broad-spectrum screening. Techniques highlighted include isothermal amplification with multiple targets, CRISPR/Cas-based systems engineered for mismatch tolerance or using several guide RNAs, and synthetic biosensors aimed at conserved viral motifs. These methods use redundancy and flexibility in targeting genetic material to maintain sensitivity even as viruses evolve.
The second strategy emphasizes precise typing capabilities, which are necessary for identifying single-nucleotide differences between virus strains. Such high-resolution detection is crucial for tracking transmission chains, distinguishing vaccine-resistant mutants, and confirming the presence of variants of concern. Approaches in this area involve designing allele-specific probes for qPCR, modifying CRISPR/Cas systems with synthetic mismatches or high-fidelity enzymes, and employing Pyrococcus furiosus Argonaute paired with RT-PCR for single-nucleotide resolution.
The researchers conclude that combining these two strategies—broad surveillance tools alongside highly specific confirmatory tests—will be essential for effective management of rapidly evolving pathogens. They note that integrating these capabilities into portable point-of-care devices informed by real-time genomic data could enhance public health responses by enabling targeted interventions more quickly.
